Keratoconus treatment - accelerated CXL outcomes comparable to conventional CXL in study


Dermot McGrath
Published: Thursday, September 1, 2016
CLINICAL EVALUATION
Clinical evaluation was carried out at six months, 12 months and then every six months subsequently up to 24 months. Examinations included uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), topography measurements and clinical tolerance of the treatment. Efficacy criteria was categorised according to Kmax with “progression” defined as a mean Kmax more than 1.0D, “stability” less than 1.0D and “regression” more than -1.0D. At 24 months, results were marginally better for C-CXL: the mean Kmax for C-CXL was -0.92D (±1.01), mean Kmin was -0.73D (±0.88) and mean cylinder was -0.19D (0.61). For A-CXL, the mean Kmax was -0.59D (±0.77), Kmin was -0.34D (±0.50) and -0.25D (±0.55). In terms of evolution profiles, C-CXL reported 70.5 per cent stable, 10.6 per cent progression and 18.9 per cent regression, while the figures for A-CXL were 71.3 per cent, 11 per cent and 17.7 per cent, respectively. Antoine Robinet: antoine.robinet-perrin@hotmail.frLatest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.